Mark P Connolly1,2, Nikolaos Kotsopoulos3,4, Aomesh Bhatt5, Maarten J Postma6,7,8,9. 1. Global Market Access Solutions Sarl, St-Prex, Switzerland. m.connolly@rug.nl. 2. Unit of Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. m.connolly@rug.nl. 3. Global Market Access Solutions Sarl, St-Prex, Switzerland. 4. Department of Economics, University of Athens, Athens, Greece. 5. Reckitt Benckiser Research and Development, Slough, Berkshire, SL1 3UH, UK. 6. Unit of Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands. 7. Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands. 8. Department of Economics, Econometrics and Finance, University of Groningen, Faculty of Economics and Business, Groningen, The Netherlands. 9. Department of Pharmacology and Therapy, Airlangga University, Surabaya, Indonesia.
Authors: Deborah J Schofield; Rupendra N Shrestha; Richard Percival; Megan E Passey; Simon J Kelly; Emily J Callander Journal: BMC Public Health Date: 2011-06-01 Impact factor: 3.295